KUALA LUMPUR: Optimax Holdings Bhd posted revenue of RM29.77 million for the third quarter (Q3) ended 30 September 2021 (FY21), an increase of 63.64 per cent from the RM18.19 million in the same quarter last year.
Net profit also showed improvement, rising 90.40 per cent to RM5.58 million compared to RM2.93 million last year.
The leading private eye specialist's central Peninsular Malaysia operations remained the largest revenue contributor, providing RM22.42 million or 75.33 per cent of total revenue for Q3 FY21, compared with RM11.23 recorded in Q3 FY20.
Operations in the south and north Peninsular Malaysia contributed RM3.67 million and RM3.21 million or 12.32 per cent and 10.78 per cent respectively to the total revenue, while East Malaysia contributed RM469,000 or 1.58 per cent of the total revenue.
Chief executive officer Sandy Tan said the improvement in Q3 was attributed to the economic re-opening with the easing of Covid-19 restrictions.
"We saw a gradual recovery in the number of patients, including patients for refractive surgeries and cataract surgeries which were earlier advised to postpone their procedures due to the restrictions," she said in a statement today.
For the nine-month (9M) period, Optimax reported revenue of RM62.29 million, an increase of 52.64 per cent from the RM40.81 million in the same period last year.
Net profit rose 118.49 per cent to RM9.07 million compared to RM4.15 million for 9M FY20.
"Our improvement in the quarter was also bolstered by involvement in the national vaccination programme and MyMedic@Wilayah organised by ProtectHealth Corporation Sdn Bhd and the Ministry of Federal Territories, which provided a new revenue stream.
"Patient numbers were also supported by continued efforts to offer promotions through online marketing platforms, which reflected positively on revenue.
"We are increasing our marketing efforts to reach a wider network of customers through digital marketing, exhibitions, and roadshows," Sandy said.
Optimax has expanded its market presence in the country by establishing a new ambulatory care centre (ACC) in Bahau, Negeri Sembilan, undergoing renovation works and is targeted to complete by the second quarter (Q2) FY22.
Moving forward, the company is planning an expansion to the east coast of Peninsular Malaysia by setting up several satellite clinics and forming an ACC network to connect the major states.
"We are confident that Optimax's prospects remain intact for FY21 underpinned by an economic recovery supported by a successful rollout of the national vaccination programme.
"This will enable us to expand our market reach further in the country," Sandy said.
For FY21, Optimax board has declared an interim tax-exempt dividend of 1.90 sen per ordinary share totalling RM5.13 million in respect of the financial year ending 31 December 2021.
The entitlement date is fixed on 10 December 2021, and Optimax will make payment on 24 December 2021.
At a recent extraordinary general meeting (EGM), the company's shareholders also passed a proposal to approve a bonus issue of 67.5 million warrants based on one warrant for every four existing ordinary shares in Optimax.
Shareholders also approved the establishing an employees' share option scheme (ESOS) involving up to 20 per cent of the total number of issued shares of Optimax.